1. A new adverse drug reaction – pigmented purpuric dermatosis caused by osimertinib administration – a case report. (14th May 2022) Authors: Tabka, Mariem; Frioui, Refka; Berardi, Giulia; Mouffak, Amelle; Lepelly, Marion; Decroisette, Chantal Journal: International journal of dermatology Issue: Volume 61:Number 10(2022) Page Start: e380 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗